-
公开(公告)号：US20220211610A1
公开(公告)日：2022-07-07
申请号：US17605468
申请日：2020-04-24
申请人： LACTOMASON CO., LTD.
发明人： Min Gyu JEON , Ji Yeon LEE , Do Seon HONG
摘要： The present disclosure relates to a skin whitening cosmetic composition comprising Lactobacillus rhamnosus LM1011 having immunostimulating activity, and more particularly provides a skin whitening cosmetic composition comprising Lactobacillus rhamnosus LM1011, which reduces melanin production by regulating tyrosinase activity, as an active ingredient.
-
公开(公告)号：US20230143524A1
公开(公告)日：2023-05-11
申请号：US17796315
申请日：2022-01-21
申请人： LACTOMASON CO., LTD.
发明人： Minn SOHN , Tae Rahk KIM , Woo Jung PARK
IPC分类号： A61K35/747 , A61P29/00
CPC分类号： A61K35/747 , A61P29/00
摘要： The present disclosure relates to a strain of Lactobacillus reuteri LM1071 (KCCM12650P) and a composition for relieving menstrual pain, comprising the same.
A strain of Lactobacillus reuteri LM1071 (KCCM12650P) according to an embodiment of the present disclosure can relieve premenstrual syndrome by reducing NO, prostaglandin E2 and leukotriene in blood and increasing epoxyeicosatrienoic acid (EET) and the production ratio of prostaglandin E1/prostaglandin E2. Therefore, the strain can be applied to food compositions, health functional food compositions, pharmaceutical compositions and the like.-
公开(公告)号：US11571448B2
公开(公告)日：2023-02-07
申请号：US16645185
申请日：2018-09-06
发明人： Han Soo Park
IPC分类号： A61K35/747 , A61K35/00 , A23L33/135 , A23K10/18 , A23L33/00 , A61P3/04 , A61P3/10 , A61K9/00 , C12N1/20 , C12R1/225
摘要： The present invention relates to a Lactobacillus rhamnosus LM1019 strain (accession number KCCM12308P), and a composition for preventing and treating obesity or diabetes mellitus, comprising the same. Specifically, the Lactobacillus rhamnosus LM1019 strain of the present invention reduces fat cells, neutral fats, subcutaneous fats, and cholesterol, thus having an effect of preventing and treating obesity, and also reduces the blood glucose concentration and the blood insulin concentration, thereby inhibiting insulin resistance and thus having an effect of preventing and treating diabetes mellitus.
-
公开(公告)号：US11684642B2
公开(公告)日：2023-06-27
申请号：US15734900
申请日：2020-11-11
发明人： Min Gyu Jeon , Shin Young Park , Yun Yeon Kim
IPC分类号： A61K35/745 , A23L33/135 , A61P17/00
CPC分类号： A61K35/745 , A23L33/135 , A61P17/00 , A23V2002/00 , A23Y2300/21
摘要： A composition for the treatment of atopic dermatitis, the composition including, as an active ingredient, Bifidobacterium animalis subsp. lactis LM1017, and more specifically provided is a composition for the treatment of atopic dermatitis. The composition includes, as an active ingredient, a navel Bifidobacterium animalis subsp. lactis LM1017 which adjusts the NF-κB signal transduction pathway, and thus inhibits the expression of proinflammatory cytokines.
-
公开(公告)号：US20230055117A1
公开(公告)日：2023-02-23
申请号：US17893840
申请日：2022-08-23
发明人： Han Soo Park
IPC分类号： C12N1/20 , A23K50/50 , A23K10/18 , A23L33/135 , A61P1/16 , A61P9/00 , A61P3/06 , A61P3/10 , A61P29/00 , A61K35/747
摘要： The present invention relates to a novel strain of Lactobacillus fermentum LM1016 deposited with the Korean Culture Center of Microorganisms under accession number KCCM12468P. The novel strain of the present invention has an effect of treating or preventing cardiovascular diseases, obesity, fatty liver or diabetes mellitus.
The present invention relates to a composition comprising the strain, and the composition may be used in a pharmaceutical product, a health functional food, a dairy product, a fermented product, a food additive and an animal feed and the like.-
公开(公告)号：US20210106630A1
公开(公告)日：2021-04-15
申请号：US16645185
申请日：2018-09-06
发明人： Han Soo Park
IPC分类号： A61K35/747 , C12R1/225 , C12N1/20 , A61P3/10 , A61P3/04 , A61K9/00 , A23L33/135 , A23L33/00 , A23K10/18
摘要： The present invention relates to a Lactobacillus rhamnosus LM1019 strain (accession number KCCM12308P), and a composition for preventing and treating obesity or diabetes mellitus, comprising the same. Specifically, the Lactobacillus rhamnosus LM1019 strain of the present invention reduces fat cells, neutral fats, subcutaneous fats, and cholesterol, thus having an effect of preventing and treating obesity, and also reduces the blood glucose concentration and the blood insulin concentration, thereby inhibiting insulin resistance and thus having an effect of preventing and treating diabetes mellitus.
-
7.发明公开公开(公告)号：US20240307468A1
公开(公告)日：2024-09-19
申请号：US18419725
申请日：2024-01-23
发明人： Minn SOHN , Je Seong PARK , Ye Ji YOU , Young Sup SHIN , Sung Hwan KIM , Chul Hong KIM
IPC分类号： A61K35/747 , A23C9/123 , A61K35/744 , A61K35/745 , C12N1/20 , C12R1/225
CPC分类号： A61K35/747 , A23C9/1234 , A61K35/744 , A61K35/745 , C12N1/205 , A23V2400/113 , A23V2400/123 , A23V2400/175 , A23V2400/249 , A23V2400/531 , C12R2001/225
摘要： The present disclosure relates to an immune-enhancing composition comprising Lactobacillus rhamnosus LM1019 and starter strains. An immune-enhancing composition comprising Lactobacillus rhamnosus LM1019 and starter strains according to the present disclosure has an excellent immune-enhancing effect by increasing the amount of nitric oxide (NO) produced and improving the TNF-α secretion ability. Also, since the immune-enhancing composition contains the starter strain, it can be used to produce fermented milk. Under the provisions of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, the Lactobacillus rhamnosus LM1019 strain was deposited with the international depositary authority: the Korean Culture Center of Microorganisms (KCCM) on Aug. 11, 2017, under the Accession Number: KCCM12308P.
-
公开(公告)号：US20240150707A1
公开(公告)日：2024-05-09
申请号：US18412654
申请日：2024-01-15
申请人： LACTOMASON CO., LTD.
发明人： Minn SOHN , Tae Rahk KIM
IPC分类号： C12N1/20 , A61K35/747 , A61P15/00 , C12R1/225
CPC分类号： C12N1/205 , A61K35/747 , A61P15/00 , C12R2001/225
摘要： The present disclosure relates to a strain of Lactobacillus gasseri LM1065 (KCCM13018P) and a composition of relieving premenstrual syndrome containing the strain.
A strain of Lactobacillus gasseri LM1065 (KCCM13018P) according to an embodiment of the present disclosure can relieve premenstrual syndrome by reducing NO in blood and TL-6 gene expression and increasing the production ratio of prostaglandin E1/prostaglandin E2 in blood and DGLA levels. Therefore, the strain can be applied to food compositions, health functional food compositions, pharmaceutical compositions, and the like.-
公开(公告)号：US20220002664A1
公开(公告)日：2022-01-06
申请号：US15734909
申请日：2020-09-25
申请人： LACTOMASON CO., LTD.
发明人： Min Gyu JEON , Tae Rahk KIM , Su Bin JO , Soo Yeon JEONG
IPC分类号： C12N1/20
摘要： The present disclosure relates to Lactobacillus reuteri LM1071 (KCCM12650P) and a composition containing Lactobacillus reuteri LM1071 for improving the intestinal environment.
Lactobacillus reuteri LM1071 (KCCM12650P) according to an embodiment of the present disclosure does not have hemolysis and biogenic amine production capability and has excellent biosafety and excellent intestine adhesion and thus can improve the intestinal environment and improve the intestinal health. Therefore, the strain can be applied to pharmaceutical compositions, food compositions, health functional food compositions, feed compositions, and the like.-
公开(公告)号：US11685896B2
公开(公告)日：2023-06-27
申请号：US16426319
申请日：2019-05-30
申请人： LACTOMASON CO., LTD.
发明人： Il Seon Jung , Jong Bin Yun , Minn Sohn
CPC分类号： C12N1/20 , A23K10/16 , A23L29/065 , A23L33/135 , C12M25/02 , C12N1/005 , C12N1/02
摘要： The present disclosure relates to a method for preparing killed lactic acid bacteria using a bioreactor including a culture device and a membrane filter, and to killed lactic acid bacteria prepared by the preparation method.
-
-
-
-
-
-
-
-
-
搜索结果
13 条记录 (耗时 0.014 秒)
